Tuberculosis, lung infections, interstitial lung disease, and socioeconomic issues in AJRCCM 2001

American Journal of Respiratory and Critical Care Medicine

Volumn 165, Issue 5, 2002, Pages 631-641

  Tobin, Martin J ^a,b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b HINES VA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; BCG VACCINE; BERYLLIUM; BLEOMYCIN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; DNA; HLA ANTIGEN; INTERLEUKIN 6; METHOTREXATE; SILICON DIOXIDE; SOMATOMEDIN C; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ALLERGIC PNEUMONITIS; ANIMAL MODEL; ASTHMA; HEALTH ECONOMICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS PROTEINOSIS; LUNG DISEASE; LUNG FIBROSIS; LUNG INFECTION; LUNG SARCOIDOSIS; LUNG TOXICITY; LYMPHANGIOLEIOMYOMATOSIS; NONHUMAN; OCCUPATIONAL DISEASE; OCCUPATIONAL LUNG DISEASE; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; SOCIOECONOMICS; TUBERCULOSIS;

EID: 0036499773     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.165.5.2201064     Document Type: Review

References (86)

1. Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis
2. Mycobacterial genetics: The sensibility of antisense
3. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease
4. Reinfection tuberculosis: How important is it?
5. Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island
6. Tuberculosis transmission-rogue pathogen or rogue patient?
7. What nobody needs to know about airborne infection
8. Use of audio computer-assisted self-interviews to assess tuberculosis-related risk behaviors
9. Tuberculosis in the foreign-born population of Tarrant county, Texas by immigration status
10. Controlling tuberculosis among foreign born within industrialized countries: Expensive band-aids
11. Transmission of Mycobacterium tuberculosis to contacts of HIV-infected tuberculosis patients
12. Miniature chest radiograph screening for tuberculosis in jails: A cost-effectiveness analysis
13. Jails, chest radiography, and the elimination of tuberculosis
14. Interpretation of the tuberculin skin test in Mycobacterium bovis BCG-vaccinated Singaporean schoolchildren
15. The effect of BCG vaccination on tuberculin skin testing? Does it matter?
16. Repeat tuberculin testing in BCG-vaccinated subjects in the UK: The booster effect varies with the time of reading
17. Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations-United States, 2001
18. Hepatotoxicity from rifampin plus pyrazinamide: Lessons for policymakers and messages for care providers
19. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells
20. Diagnosing latent tuberculosis infection: The 100-year upgrade
21. Changing approaches to the diagnosis of tuberculosis
22. The need for new drugs against tuberculosis: Obstacles, opportunities, and next steps
23. Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy
24. Antiapoptotic effects of IL-15 on pulmonary Tc1 cells of patients with human immunodeficiency virus infection
25. Low exhaled nitric oxide and a polymorphism in the NOS I gene is associated with acute chest syndrome
26. Pulmonary complications of HIV infection: Report of the Fourth NHLBI Workshop
27. Prevalence of bronchial hyperresponsiveness among HIV-infected men
28. Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia
29. Oral clearance and pathogenic oropharyngeal colonization in the elderly
30. Etiology of severe pneumonia in the very elderly
31. Guidelines for the management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, antimicrobial therapy, and prevention
32. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis
33. Analysis of tumor necrosis factor-α, lymphotoxin-α, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis
34. Idiopathic pulmonary fibrosis: Relationship between histopathologic features and mortality
35. Nonspecific interstitial pneumonia: Nobody said it's perfect
36. Histopathologic variability in usual and nonspecific interstitial pneumonias
37. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis
38. Idiopathic pulmonary fibrosis: To biopsy or not to biopsy
39. Predicting survival in idiopathic pulmonary fibrosis: Scoring system and survival model
40. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation
41. Polymyositis-dermatomyositis-associated interstitial lung disease
42. Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation
43. Differential mRNA expression of insulin-like growth factor-1 splice variants in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis
44. ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis
45. 1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-Jun-NH2-terminal kinase-dependent pathway
46. Results from a genome-wide search for predisposing genes in sarcoidosis
47. Sarcoidosis: Do our genes really matter?
48. Ace gene I/D polymorphism and sarcoidosis pulmonary disease severity
49. Highly activated T-cell receptor AV2S3(+) CD4(+) lung T-cell expansions in pulmonary sarcoidosis
50. Familial aggregation of sarcoidosis: A case-control etiologic study of sarcoidosis (ACCESS)
51. Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis
52. Abnormal pulmonary granuloma formation in osteopontin-deficient mice
53. Clinical characteristics of patients in a case control study of sarcoidosis
54. The ACCESS Study: Characterization of sarcoidosis in the United States
55. Depression in sarcoidosis
56. Examining the link between sarcoidosis and depression
57. The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis
58. Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis
59. Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis
60. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex
61. Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis
62. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis
63. Spectrum of CD4 to CD8 T-cell ratios in lymphocytic alveolitis associated with methotrexate-induced pneumonitis
64. Major histocompatibility complex and tumor necrosis factor-α polymorphisms in pigeon breeder's disease
65. Are polymorphisms the answer in hypersensitivity pneumonitis?
66. Tumor necrosis factor-α-308 promoter gene polymorphism and increased tumor necrosis factor serum bioactivity in farmer's lung patients
67. Role of molds in farmer's lung disease in Eastern France
68. Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin
69. Bleomycin-induced chronic lung damage does not resemble human idiopathic pulmonary fibrosis
70. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse
71. Contribution of small GTPase Rho and its target protein rock in a murine model of lung fibrosis
72. High beryllium-stimulated TNF-α is associated with the -308 TNF-α promoter polymorphism and with clinical severity in chronic beryllium disease
73. Surface of localized pleural plaques quantitated by computed tomography scanning: No relation with cumulative asbestos exposure and no effect on lung function
74. Detailed occupational history: The cornerstone in diagnosis of asbestos-related lung disease
75. Pseudoasbestos bodies and fibers in bronchoalveolar lavage of refractory ceramic fiber users
76. 1 and subsequent respiratory symptoms, illnesses, and mortality in coal miners in the United States
77. Longitudinal changes in pulmonary function and respiratory symptoms in cotton textile workers: A 15-yr follow-up study
78. Occupation, chronic bronchitis, and lung function in young adults: An international study
79. Role of snoring and daytime sleepiness in occupational accidents
80. Tumor necrosis factor receptor deficiency alters matrix metalloproteinase 13/tissue inhibitor of metalloproteinase 1 expression in murine silicosis
81. When the chest X-ray does not tell the whole story: A tale of miners, selection bias, and the healthy worker effect
82. Respiratory health in a globalizing world
83. The buck stops here
84. The COMPACCS Study: Questions left unanswered
85. Rip Van Winkle: Will academic pulmonary programs ever wake up to sleep?
86. Practice expense costs in pulmonary and critical care practices: Is providing patient care still economically feasible?